These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23049906)

  • 1. MiR-145 regulates epithelial to mesenchymal transition of breast cancer cells by targeting Oct4.
    Hu J; Guo H; Li H; Liu Y; Liu J; Chen L; Zhang J; Zhang N
    PLoS One; 2012; 7(9):e45965. PubMed ID: 23049906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
    Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
    Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
    Korpal M; Lee ES; Hu G; Kang Y
    J Biol Chem; 2008 May; 283(22):14910-4. PubMed ID: 18411277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.
    Kong D; Li Y; Wang Z; Banerjee S; Ahmad A; Kim HR; Sarkar FH
    Stem Cells; 2009 Aug; 27(8):1712-21. PubMed ID: 19544444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
    Ahmad A; Aboukameel A; Kong D; Wang Z; Sethi S; Chen W; Sarkar FH; Raz A
    Cancer Res; 2011 May; 71(9):3400-9. PubMed ID: 21389093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 9. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
    Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ
    Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The MicroRNA miR-205 inhibits epithelial-messenchymal transition in HK-2 cells by down-regulating ZEB1 and ZEB2 expressions].
    Cao LY; Yang J; Fu XG; Lin YH; Lin F; Huang BY
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Dec; 36(12):1700-1705. PubMed ID: 27998868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
    Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
    Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
    Howe EN; Cochrane DR; Richer JK
    Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.
    Guo F; Cogdell D; Hu L; Yang D; Sood AK; Xue F; Zhang W
    Oncol Rep; 2014 May; 31(5):2021-8. PubMed ID: 24677166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
    Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
    Zhang Z; Yang M; Chen R; Su W; Li P; Chen S; Chen Z; Chen A; Li S; Hu C
    Oncogene; 2014 Jun; 33(26):3374-82. PubMed ID: 23975422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.
    Tran MN; Choi W; Wszolek MF; Navai N; Lee IL; Nitti G; Wen S; Flores ER; Siefker-Radtke A; Czerniak B; Dinney C; Barton M; McConkey DJ
    J Biol Chem; 2013 Feb; 288(5):3275-88. PubMed ID: 23239884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1.
    Chang BP; Wang DS; Xing JW; Yang SH; Chu Q; Yu SY
    J Huazhong Univ Sci Technolog Med Sci; 2014 Apr; 34(2):201-206. PubMed ID: 24710933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.